Professor Jeremy Tomlinson graduated from the University of Oxford Medical School in 1995, having previously completed his undergraduate degree at the University of Cambridge. He embarked upon a career in Diabetes and Endocrinology and secured an MRC Clinical Training Fellowship in 2000 and obtained his PhD from University of Birmingham studying steroid metabolism and human obesity in 2003. Subsequently he obtained fellowships from the Wellcome Trust and most recently an MRC senior clinical fellowship investigating the pathogenesis of human obesity and insulin resistance. He is a Professor of Metabolic Endocrinology and consultant endocrinologist based in the Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford. His research investigates the pathogenesis of human obesity, insulin resistance and non-alcoholic fatty liver disease (NAFLD). His work in the NALFD field has explored the use of novel biomarkers to stage disease as well as investigating the therapeutic benefit of agents including GLP1 analogues and defining their mechanism of action. For more than 10 years, he has been part of multidisciplinary metabolic hepatology clinics working alongside hepatologists to treat patients with NAFLD.